StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

LivaNova r&d expenses

Research and development expenses are spending on new products and technology.

LivaNova's R&D Expenses for the twelve months ending Jun 30, 2026 was $213.06M, up 20.3% year over year. For fiscal 2025 it was $185.76M, up 1.8% from the year before. Over ten years it grew 15.2% a year on average. The highest annual figure on record is $193.82M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$185.76M+1.8%
FY2024Dec 31, 2024$182.51M-5.8%
FY2023Dec 31, 2023$193.82M+24.4%
FY2022Dec 31, 2022$155.81M-15.1%
FY2021Dec 31, 2021$183.41M+20.0%
FY2020Dec 31, 2020$152.90M+4.1%
FY2019Dec 31, 2019$146.85M+0.6%
FY2018Dec 31, 2018$145.95M+33.3%
FY2017Dec 31, 2017$109.52M+159.2%
FY2015Apr 24, 2015$42.25M-6.6%
FY2014Apr 25, 2014$45.22M+8.8%
FY2013Apr 26, 2013$41.55M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$53.66M+13.7%
Q1 FY2026CQ1 2026Mar 31, 2026$58.70M+55.0%
Q4 FY2025CQ4 2025Dec 31, 2025$52.12M+20.4%
Q3 FY2025CQ3 2025Sep 30, 2025$48.58M-0.5%
Q2 FY2025CQ2 2025Jun 30, 2025$47.19M+5.5%
Q1 FY2025CQ1 2025Mar 31, 2025$37.88M-17.0%
Q4 FY2024CQ4 2024Dec 31, 2024$43.31M-6.2%
Q3 FY2024CQ3 2024Sep 30, 2024$48.81M+4.9%
Q2 FY2024CQ2 2024Jun 30, 2024$44.74M-12.5%
Q1 FY2024CQ1 2024Mar 31, 2024$45.66M-8.6%
Q4 FY2023CQ4 2023Dec 31, 2023$46.17M+2.7%
Q3 FY2023CQ3 2023Sep 30, 2023$46.54M+30.3%
Q2 FY2023CQ2 2023Jun 30, 2023$51.12M+49.4%
Q1 FY2023CQ1 2023Mar 31, 2023$49.99M+22.2%
Q4 FY2022CQ4 2022Dec 31, 2022$44.93M+1.9%
Q3 FY2022CQ3 2022Sep 30, 2022$35.73M-15.2%
Q2 FY2022CQ2 2022Jun 30, 2022$34.23M-34.9%
Q1 FY2022CQ1 2022Mar 31, 2022$40.92M-8.3%
Q4 FY2021CQ4 2021Dec 31, 2021$44.10M-0.9%
Q3 FY2021CQ3 2021Sep 30, 2021$42.13M-11.1%
Q2 FY2021CQ2 2021Jun 30, 2021$52.56M+109.0%
Q1 FY2021CQ1 2021Mar 31, 2021$44.63M+24.3%
Q4 FY2020CQ4 2020Dec 31, 2020$44.48M+94.9%
Q3 FY2020CQ3 2020Sep 30, 2020$47.37M+3.2%
Q2 FY2020CQ2 2020Jun 30, 2020$25.15M-27.2%
Q1 FY2020CQ1 2020Mar 31, 2020$35.90M-17.6%
Q4 FY2019CQ4 2019Dec 31, 2019$22.83M-39.2%
Q3 FY2019CQ3 2019Sep 30, 2019$45.90M+8.2%
Q2 FY2019CQ2 2019Jun 30, 2019$34.54M+1.0%
Q1 FY2019CQ1 2019Mar 31, 2019$43.58M+37.2%
Q4 FY2018CQ4 2018Dec 31, 2018$37.56M+16.0%
Q3 FY2018CQ3 2018Sep 30, 2018$42.42M+85.2%
Q2 FY2018CQ2 2018Jun 30, 2018$34.22M+1.1%
Q1 FY2018CQ1 2018Mar 31, 2018$31.75M+55.8%
Q4 FY2017CQ4 2017Dec 31, 2017$32.39M+203.1%
Q3 FY2017CQ3 2017Sep 30, 2017$22.90M–
Q2 FY2017CQ2 2017Jun 30, 2017$33.83M–
Q1 FY2017CQ1 2017Mar 31, 2017$20.39M–
Q4 FY2015CQ1 2015Apr 24, 2015$10.69M–

More LivaNova figures

See a number that looks wrong?